Sea King Biological Transfer Fu medicine save the British special Dragon

In Saturday, the Sea King Biology issued a notice, to be held by the sea Fu drug 80% of all the shares transferred to the loss of Hong Kong stocks subsidiary of the Sea Wang Yingtorong, Haiwing Intron will be 0.8 yuan per share of the price issue of 542 million shares of new domestic shares, to pay 443 million yuan for the transfer of the price.　　According to the plan, in the sea Wang Yingtorong successful issue and placing 189 million new foreign capital shares (H-shares), and other conditions, the Sea King will be the fu of the sea to the possession of the drug 80% shares transferred to Haiwing Intron. Sea King Biological Act is called support, actually rescue. According to public information, Haiwang has not been profitable in recent years. And the Sea Fu medicine as of April 30 this year, the net assets value is 117 million yuan, this year 1-April realized net profit 19.0662 million yuan.